Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains

The ongoing severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic had brought disastrous consequences throughout the entire world. While several manufactured vaccines have been approved for emergency use, continuous efforts to generate novel vaccines are needed. In this study, we dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Ki-Back, Kang, Hae-Ji, Yoon, Keon-Woong, Lee, Hae-Ahm, Moon, Eun-Kyung, Han, Beom-Ku, Quan, Fu-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402567/
https://www.ncbi.nlm.nih.gov/pubmed/34452044
http://dx.doi.org/10.3390/vaccines9080920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402567/
https://www.ncbi.nlm.nih.gov/pubmed/34452044
http://dx.doi.org/10.3390/vaccines9080920

Ejemplares similares